| Literature DB >> 34565302 |
Qing Wang1, Kuo Liu1, Changming Jin1.
Abstract
This study explored the clinical meaning of miR-378a-3p in sepsis and its influence on sepsis-induced inflammation and cardiac dysfunction. Serum levels of miR-378a-3p were detected by quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). The Receiver Operating Characteristic (ROC) curve was used to evaluate its diagnostic value. The effects of miR-378a-3p on inflammation and cardiac function were evaluated by monitoring left ventricular systolic pressure (LVSP), left ventricular and end-diastolic pressure (LVEDP), maximum rate of change in left ventricular pressure (± dp/dtmax) and detecting the levels of troponin I (cTnI), creatine kinase isoenzyme MB (CK-MB), tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), and interleukin-1β (IL-1β) via enzyme linked immunosorbent assay (ELISA). Serum miR-378a-3p was increased in sepsis patients and rat model. ROC curve indicated that miR-378a-3p might have diagnostic significance for sepsis miR-378a-3p antagomir improved the cardiac function by upregulating the levels of LVSP and ± dp/dtmax, and decreasing the levels of LVEDP, cTnI and CK-MB in rat model. miR-378a-3p antagomir also significantly alleviated the inflammatory responseby down-regulating the expression of TNF-a, IL-6, and IL-1β. Besides, logistics regression analysis illustrated that miR-378a-3p was an independent influencing factor for the onset of cardiac dysfunction in sepsis. miR-378a-3p has the potential as a diagnostic biomarker for sepsis and decreasing the level of miR-378a-3p had the ability to ameliorate cardiac dysfunction and inflammatory response caused by sepsis.Entities:
Keywords: Sepsis; biomarker; diagnosis; miR-378a-3p
Mesh:
Substances:
Year: 2021 PMID: 34565302 PMCID: PMC8806767 DOI: 10.1080/21655979.2021.1985339
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 3.269
Comparison of the clinical charateristics between the two groups of study objects
| Clinical variables | Health individuals | Sepsis patients | |
|---|---|---|---|
| Age (year) | 53.44 ± 11.50 | 54.61 ± 11.29 | 0.529 |
| Gender (male/female) | 28/44 | 39/41 | 0.221 |
| BMI (kg/m2) | 21.79 ± 2.96 | 22.59 ± 3.21 | 0.114 |
| Scr (mg/dL) | 1.12 ± 0.26 | 1.57 ± 0.41 | *** |
| Albumin (g/L) | 41.25 ± 5.43 | 26.79 ± 4.31 | *** |
| WBC (×109/L) | 7.14 ± 1.53 | 16.73 ± 5.02 | *** |
| CRP (mg/L) | 5.55 ± 2.98 | 79.64 ± 15.97 | *** |
| PCT (ng/mL) | 0.05 ± 0.02 | 11.41 ± 3.78 | *** |
| APACHE II score | - | 12.53 ± 3.34 | - |
| SOFA score | - | 5.24 ± 1.35 | - |
Note: BMI, body mass index; Scr, serum creatinine; WBC, white blood cell; CRP, C-reactive protein; PCT, procalcitonin; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; ***, P < 0.001.
Figure 1.qRT-PCR analysis of serum expression level of miR-378a-3p in sepsis patients and healthy controls
Figure 2.The receiver operating characteristic curve was established to evaluate the diagnostic value of miR-378a-3p in sepsis patients
The relation of miR-378a-3p expression with the clinical variables
| Parameters | Correlation (r) | |
|---|---|---|
| Scr (mg/dL) | 0.040 | 0.725 |
| Albumin (g/L) | 0.019 | 0.868 |
| WBC (×109/L) | 0.412 | <0.001 |
| CRP (mg/L) | 0.194 | 0.084 |
| PCT (ng/mL) | 0.319 | 0.004 |
| APACHE II score | 0.432 | <0.001 |
| SOFA score | 0.698 | <0.001 |
Note: BMI, body mass index; Scr, serum creatinine; WBC, white blood cell; CRP, C-reactive protein; PCT, procalcitonin; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment.
Association of different variables with the occurrence of cardiac dysfunction
| Variables | OR | 95% CI | |
|---|---|---|---|
| MiR-378a-3p | 3.000 | 1.077–8.356 | 0.036 |
| Age (year) | 1.091 | 0.402–2.958 | 0.864 |
| Gender (male/female) | 1.642 | 0.603–4.475 | 0.332 |
| BMI (kg/m2) | 1.651 | 0.628–4.344 | 0.310 |
| Scr (mg/dL) | 1.484 | 0.516–4.270 | 0.464 |
| Albumin (g/L) | 1.513 | 0.525–4.356 | 0.443 |
| WBC (×109/L) | 1.169 | 0.427–3.203 | 0.761 |
| CRP (mg/L) | 1.148 | 0.397–3.324 | 0.798 |
| PCT (ng/mL) | 1.917 | 0.665–5.841 | 0.221 |
| APACHE II score | 1.506 | 0.539–4.207 | 0.435 |
| SOFA score | 2.853 | 0.915–8.901 | 0.071 |
Abbreviations: BMI, body mass index; Scr, serum creatinine; WBC, white blood cell; CRP, C-reactive protein; PCT, procalcitonin; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment
Figure 3.Effects of miR-378a-3p on cardiac function in sepsis rat models. (a) Serum miR-378a-3p expression in different groups of rat models. Changes of (b) LVSP, (c) LVEDP, (d) cTnI, (e) CK-MB and (f) ± dp/dtmax in experimental groups
Figure 4.Effects of miR-378a-3p on inflammatory response in sepsis rat models. Changes of (a) TNF-α, (b) IL-1β and (c) IL-6 in the serum of sepsis rats